P

    Pulse Biosciences Inc (PLSE)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $50.33
    +2.76 (+5.80%)

    Market Cap: $3.39B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(13/30)
    Avg Surprise
    -2.79%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.29
    Range$-0.30 - $-0.29
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.24+18.6%
    60d ago$-0.28+3.4%
    30d ago$-0.28+3.4%
    7d ago$-0.28+3.4%
    Current$-0.29
    Revenue Consensus
    $500000
    Range$400000 - $600000
    3 analysts
    Dec 31, 2026
    EPS Consensus$-0.30
    Range$-0.32 - $-0.29
    2 analysts
    Revenue Consensus
    $533340
    Range$166670 - $766670
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.30---
    Sep 26EST
    		-$-0.29---
    Jun 26
    		$-0.36$-0.31-16.13%Miss-28.6%
    Mar 26
    		$-0.24$-0.22-9.73%Miss+3.5%
    Dec 25
    		$-0.18$-0.21+14.29%Beat+42.4%
    Sep 25
    		$-0.29$-0.31+6.45%Beat-39.7%
    Jun 25
    		$-0.28$-0.26-7.69%Miss-40.6%
    Mar 25
    		$-0.25N/AN/ABeat-39.0%
    Dec 24
    		$-0.31$-0.24-30.17%Miss-44.2%
    Sep 24
    		$-0.21$-0.24+13.50%Beat-9.3%
    Jun 24
    		$-0.20$-0.20+0.45%Beat+9.5%
    Mar 24
    		$-0.18$-0.24+25.00%Beat+30.8%
    Dec 23
    		$-0.22$-0.24+9.71%Beat+13.3%
    Sep 23
    		$-0.19$-0.22+13.64%Beat+61.2%
    Jun 23
    		$-0.22$-0.24+8.33%Beat+50.0%
    Mar 23
    		$-0.26$-0.22-18.18%Miss+55.2%
    Dec 22
    		$-0.25$-0.24-4.17%Miss+51.9%
    Sep 22
    		$-0.49$-0.45-8.89%Miss-2.1%
    Jun 22
    		$-0.44$-0.40-10.00%Miss+8.3%
    Mar 22
    		$-0.58$-0.52-11.54%Miss-31.8%
    Dec 21
    		$-0.52$-0.51-1.96%Miss+3.7%
    Sep 21
    		$-0.48$-0.53+9.43%Beat+5.9%
    Jun 21
    		$-0.48$-0.52+7.69%Beat+9.4%
    Mar 21
    		$-0.44$-0.49+10.20%Beat+22.8%
    Dec 20
    		$-0.54$-0.45-20.00%Miss+18.2%
    Sep 20
    		$-0.51$-0.44-15.91%Miss+10.5%
    Jun 20
    		$-0.53$-0.50-6.00%Miss+3.6%
    Mar 20
    		$-0.57$-0.47-21.28%Miss-16.3%
    Dec 19
    		$-0.66$-0.61-8.20%Miss-29.4%
    Sep 19
    		$-0.57$-0.61+6.56%Beat+10.9%
    Jun 19
    		$-0.55$-0.51-7.84%Miss-1.9%
    Mar 19
    		$-0.49$-0.44-11.36%Miss+3.9%
    Dec 18
    		$-0.51$-0.51+0.00%Beat+1.9%
    Sep 18
    		$-0.64N/AN/ABeat-23.1%
    Jun 18
    		$-0.54N/AN/ABeat-25.6%
    Mar 18
    		$-0.51N/AN/ABeat-121.7%
    Dec 17
    		$-0.52N/AN/ABeat-146.4%
    Sep 17
    		$-0.52N/AN/ABeat-150.2%
    Jun 17
    		$-0.43N/AN/ABeat-
    Mar 17
    		$-0.23N/AN/ABeat-
    Dec 16
    		$-0.21N/AN/ABeat-
    Sep 16
    		$-0.21N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-46.98EV/EBITDA-1.81x
    Price/FCF-56.73xFCF Yield-1.76%
    Profitability
    Profit Margin0.00%Operating Margin-5823.00%
    ROE-78.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio9.63xQuick Ratio9.61x
    Trading Statistics
    Beta1.58Avg Volume418.15K
    52-Week High$50.9052-Week Low$12.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$48.40
    SMA 20$45.31
    SMA 50$35.80
    SMA 200$23.30
    EMA 10$47.87
    EMA 20$44.98
    EMA 50$38.14
    EMA 200$26.63

    MACD

    Line: 4.05Signal: 4.25Hist: -0.20

    ADX

    ADX: 68.0+DI: 29.7-DI: 6.2

    Aroon & PSAR

    Aroon Up84.0
    Aroon DownN/A
    PSAR$46.06

    Bollinger Bands

    Upper Band$53.25
    Lower Band$37.37
    %B Position3504%(Upper)
    Band Width0.82

    RSI (14-Day)

    Overbought
    71.9

    Momentum Oscillators

    Stoch %K78.9
    Stoch %D78.0
    Williams %R-6.6
    ROC (10d)7.6%
    Momentum3.54
    CCI (20d)89.9
    MFI (14d)71.7

    Volatility Measures

    ATR (14d)$2.77(5.5%)
    StdDev (20d)3.97
    Hist Vol59.1%(High)

    Volume Flow

    VWAP$49.50
    OBV9.1M
    AD Line1.6M
    CMF (20d)0.088

    Volume Metrics

    Avg Vol (20d)421.4K
    Vol Ratio1.6x(High)
    VWMA (20d)$45.45

    Pivot Points

    R3$50.70
    R2$49.85
    R1$48.71
    Pivot Point$47.86
    S1$46.72
    S2$45.87
    S3$44.73

    Advanced Oscillators

    TSI46.27
    Ultimate Osc57.1
    KST492.27

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$434,000$401,000$264,000$86,000$0$0$1.66M$0$0$0$1.74M$0
    Cost of Revenue$273,000$370,000$260,000$279,000$0$0$832,000$0$0$0$304,000$0
    Gross Profit$161,000$31,000$4,000$-193,000$0$0$832,000$0$0$0$1.44M$0
    Operating Expenses$25.43M$19.18M$18.26M$20.17M$20.27M$18.04M$20.26M$13.65M$11.73M$10.62M$12.53M$11.25M
    R&D$16.98M$12.59M$10.93M$11.39M$12.09M$10.31M$10.66M$7.70M$7.23M$6.74M$7.80M$7.47M
    SG&A$8.46M$6.59M$7.33M$8.78M$8.19M$7.73M$9.60M$5.95M$4.50M$3.87M$4.73M$3.78M
    Operating Income$-25,272,000$-19,150,000$-18,253,000$-20,367,000$-20,275,000$-18,044,000$-20,261,000$-13,655,000$-11,726,000$-10,615,000$-12,533,000$-11,252,000
    Interest Income$600,000$593,000$853,000$1.00M$1.13M$1.25M$893,000$976,000$343,000$478,000$600,000$686,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-24,657,000$-18,581,000$-17,433,000$-19,385,000$-19,168,000$-16,795,000$-19,385,000$-12,680,000$-11,383,000$-10,137,000$-11,933,000$-10,566,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-24,657,000$-18,581,000$-17,433,000$-19,385,000$-19,168,000$-16,795,000$-19,385,000$-12,680,000$-11,383,000$-10,137,000$-11,933,000$-10,566,000
    EBITDA$-25,003,000$-18,919,000$-17,994,000$-20,686,000$-20,298,000$-17,493,000$-19,974,000$-13,362,000$-11,428,000$-10,316,000$-12,229,000$-10,953,000
    EBIT$-25,257,000$-19,174,000$-18,253,000$-20,386,000$-20,297,000$-18,050,000$-20,261,000$-13,656,000$-11,726,000$-10,615,000$-12,533,000$-11,252,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PLSE

    News

    Pulse Biosciences stock hits all-time high at 48.92 USD

    Pulse Biosciences (PLSE) stock reached an all-time high of $48.92, driven by a 248% year-to-date performance and strong investor confidence in its biosciences innovations. Despite recent misses in Q2 2026 earnings and revenue estimates, analysts anticipate significant revenue growth and have issued "buy" ratings, highlighting progress in clinical trials and technology development. However, InvestingPro suggests caution as the stock appears overvalued and in overbought territory.

    Investing.com•8/21/26•
    Bullish

    Pulse Biosciences stock hits all-time high at 48.92 USD By Investing.com

    Pulse Biosciences (PLSE) stock has reached an all-time high of $48.92, reflecting a 1-year return of 186.1% and a year-to-date performance of 248%, pushing its market capitalization to $3.46 billion. Despite this momentum, InvestingPro analysis indicates the stock is overvalued and trading near its 52-week high with an overbought RSI. The company expects significant revenue growth of 429% this year, although profitability is not anticipated yet, and recently missed Q2 2026 earnings and revenue estimates.

    Investing.com Nigeria•8/21/26•
    Somewhat-Bullish

    Net income before discontinued operations of Pulse Biosciences, Inc. – HAM:6L8

    This article presents financial data for Pulse Biosciences, Inc. (HAM:6L8) on TradingView, specifically focusing on its net income before discontinued operations. It highlights that the market was closed with no trades recorded at the time of viewing. The content also lists various features and services offered by TradingView.

    TradingView•8/21/26•
    Neutral

    Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE

    Bank of America Corp DE has increased its stake in Pulse Biosciences, Inc (NASDAQ:PLSE) by 8.2% in the first quarter, now owning 866,061 shares worth over $18 million. Several other institutional investors also adjusted their positions in PLSE. The article also covers Pulse Biosciences' recent price performance, earnings, and analyst ratings, which currently indicate a "Moderate Buy" consensus.

    MarketBeat•8/20/26•
    Somewhat-Bullish

    Pulse Biosciences (PLSE) Launched A $75 Million Offering, Is The Upside Already Priced In?

    Pulse Biosciences (PLSE) recently reported wider second-quarter losses and initiated a $75 million equity offering, despite a significant run-up in its share price. The company is advancing its atrial fibrillation nsPFA program, but its current valuation of $46.79 is considered overvalued compared to a narrative fair value of $41.00. Investors are advised to examine key reward and warning signs as the company faces hurdles like ongoing losses and execution risks in converting its pipeline into revenue.

    Sahm•8/19/26•
    Somewhat-Bearish

    Frequently Asked Questions About PLSE

    Does PLSE pay dividends?
    Pulse Biosciences Inc (PLSE) does not currently pay a regular dividend.
    What is PLSE's market cap?
    Pulse Biosciences Inc (PLSE) has a market capitalization of $3.39B with a current stock price of $50.33.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In